Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115114) titled 'Clinical Study of Selinoxor-Based Chemotherapy with Minimal or No Cytotoxic Agents in Treatment-Naive AML Patients Unsuitable for Intensive Therapy: Focusing on Rapid Reduction of Blast Cells' on Dec. 23, 2025.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Tongji Hospital, Tongji Medical College ,Huazhong University of Science and Technology
Condition:
Acute Myeloid Leukemia
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2024-12-30
Target Sample Size: Experimental Group:71;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.c...